Transcript: Hi, I'm Eric Secemsky; I'm the Director of Vascular Intervention at Beth Israel Deaconess Medical Center in Boston, Massachusetts. Since we spoke last year, what new clinical trial data or guideline updates have most influenced how you integrate renal denervation (RDN) into practice for patients with atrial fibrillation (AFib) and resistant hypertension (HTN)? RDN has continued to evolve.